Denali Therapeutics (DNLI) Ownership - Who owns Denali Therapeutics?
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DNLI showed earnings on August 11, 2025. You can read more about the earnings report here.